Unilever to weigh raising offer for Glaxo consumer unit
GSK rejects $68 billion Unilever offer for consumer assets, Retail News, ET Retail
Unilever slides and GSK bounces after GSK knocks back £50bn bid
Glaxosmithkline boosted by HIV drug approval and US Covid treatments
GSK Stock: Why I'm Picking Up This Undervalued Gem (NYSE:GSK)
Activist Investors Pounce on Vulnerable British Blue-Chip Firms - BNN Bloomberg
Emma Walmsley
GlaxoSmithKline chairman Jonathan Symonds accuses activist Bluebell of distortion in bid to oust Emma Walmsley
Activist investor Bluebell's offensive against European giants heats up
Second hedge fund pushes for change in leadership of GSK, GlaxoSmithKline